Esteve Drug Patent Portfolio
Esteve owns 2 orange book drugs protected by 10 US patents Given below is the list of Esteve's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US8653033 | Method for administering omega-conopeptide | 01 Oct, 2024 | Expired |
| US8765680 | Method for administering omega-conopeptide | 01 Oct, 2024 | Expired |
| US9707270 | Method for administering ω-conopeptide | 01 Oct, 2024 | Expired |
| US5364842 | Method of producing analgesia | 30 Dec, 2016 | Expired |
| US5795864 | Stable omega conopetide formulations | 27 Jun, 2015 | Expired |
Latest Legal Activities on Esteve's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Esteve.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed | 06 Oct, 2025 | US8653033 |
| Expire Patent | 25 Aug, 2025 | US9707270 |
| Maintenance Fee Reminder Mailed | 10 Mar, 2025 | US9707270 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Jan, 2025 | US8513259 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 May, 2024 | US8314083 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Feb, 2024 | US8263581 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Apr, 2023 | US9180090 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Feb, 2023 | US9119771 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Dec, 2021 | US8765680 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 Aug, 2021 | US8653033 |
|
Email Notification
Critical
| 26 Apr, 2021 | US8765680 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Apr, 2021 | US8653033 |
|
Email Notification
Critical
| 26 Apr, 2021 | US8653033 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Apr, 2021 | US8765680 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 23 Apr, 2021 | US9707270 |
Esteve's Family Patents
Esteve Drug List
Given below is the complete list of Esteve's drugs and the patents protecting them.
1. Prialt
Prialt is protected by 5 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8653033 | Method for administering omega-conopeptide |
01 Oct, 2024
(1 year, 7 months ago)
| Expired |
| US8765680 | Method for administering omega-conopeptide |
01 Oct, 2024
(1 year, 7 months ago)
| Expired |
| US9707270 | Method for administering ω-conopeptide |
01 Oct, 2024
(1 year, 7 months ago)
| Expired |
| US5364842 | Method of producing analgesia |
30 Dec, 2016
(9 years ago)
| Expired |
| US5795864 | Stable omega conopetide formulations |
27 Jun, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prialt's drug page
2. Quzyttir
Quzyttir is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(3 years from now)
| Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(3 years from now)
| Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(3 years from now)
| Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(3 years from now)
| Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Quzyttir's drug page